All Stories

  1. Vitamin D and K Supplementation Is Associated with Changes in the Methylation Profile of U266-Multiple Myeloma Cells, Influencing the Proliferative Potential and Resistance to Bortezomib

    Article • Nutrients, December 2023, MDPI AG

    PhD, MD Bartłomiej Baumert

  2. Epigenetic Alterations as Vital Aspects of Bortezomib Molecular Action

    Article • Cancers, December 2023, MDPI AG

    PhD, MD Bartłomiej Baumert

  3. VEGFR and DPP-IV as Markers of Severe COVID-19 and Predictors of ICU Admission

    Article • International Journal of Molecular Sciences, November 2023, MDPI AG

    PhD, MD Bartłomiej Baumert

  4. 5-Aza-2′-Deoxycytidine Alters the Methylation Profile of Bortezomib-Resistant U266 Multiple Myeloma Cells and Affects Their Proliferative Potential

    Article • International Journal of Molecular Sciences, November 2023, MDPI AG

    PhD, MD Bartłomiej Baumert

  5. Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients

    Article • Cancers, September 2023, MDPI AG

    PhD, MD Bartłomiej Baumert

  6. Safety of Cryopreserved Stem Cell Infusion through a Peripherally Inserted Central Venous Catheter

    Article • Cancers, February 2023, MDPI AG

    PhD, MD Bartłomiej Baumert

  7. Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives

    Article • Cancers, February 2023, MDPI AG

    PhD, MD Bartłomiej Baumert

  8. The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to Bortezomib

    Article • Nutrients, December 2022, MDPI AG

    PhD, MD Bartłomiej Baumert

  9. CXCL8, CCL2, and CMV Seropositivity as New Prognostic Factors for a Severe COVID-19 Course

    Article • International Journal of Molecular Sciences, September 2022, MDPI AG

    Dr Katarzyna L Kotfis, PhD, MD Bartłomiej Baumert

  10. Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide

    Article • Medicina, September 2022, MDPI AG

    PhD, MD Bartłomiej Baumert

  11. Brain-derived neurotrophic factor: focus on the pathogenesis of multiple myeloma and the development of treatment-induced peripheral neuropathy

    Article • Leukemia & Lymphoma, August 2022, Taylor & Francis

    PhD, MD Bartłomiej Baumert

  12. The Influence of Periodontal Diseases and the Stimulation of Saliva Secretion on the Course of the Acute Phase of Ischemic Stroke

    Article • Journal of Clinical Medicine, July 2022, MDPI AG

    PhD, MD Bartłomiej Baumert

  13. Massive atrial thrombus in sinus rhythm cardiac amyloidosis is not a wild goose chase?

    Article • Kardiologia Polska, April 2022, Polskie Towarzystwo Kardiologiczne

    PhD, MD Bartłomiej Baumert

  14. Vitamin D as a Potential Player in Immunologic Control over Multiple Myeloma Cells: Implications for Adjuvant Therapies

    Article • Nutrients, April 2022, MDPI AG

    PhD, MD Bartłomiej Baumert

  15. Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy Development

    Article • International Journal of Molecular Sciences, February 2022, MDPI AG

    PhD, MD Bartłomiej Baumert

  16. The Impact of the COVID-19 Pandemic on the Organization of Cardio-Hematology Care—A Polish Single Center Experience

    Article • Medicina, February 2022, MDPI AG

    PhD, MD Bartłomiej Baumert

  17. Case of Patient with AML with Complex Karyotype including Ultra-Rare t(4;8)(q32;q13), t(4;11)(q21;p15) and Familial Aggregation of Myeloid Malignancies

    Article • Medicina, January 2022, MDPI AG

    PhD, MD Bartłomiej Baumert

  18. Antimicrobial prophylaxis in adults and children undergoing hematopoietic cell transplantation: 2021 Polish recommendations

    Article • Acta Haematologica Polonica, December 2021, VM Media SP. zo.o VM Group SK

    PhD, MD Bartłomiej Baumert

  19. Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients

    Article • Journal of Clinical Medicine, November 2021, MDPI AG

    PhD, MD Bartłomiej Baumert

  20. The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma

    Article • Journal of Clinical Medicine, October 2021, MDPI AG

    PhD, MD Bartłomiej Baumert

  21. COVID-19 during Early Phase of Autologous Stem Cell Transplantation

    Article • Medicina, July 2021, MDPI AG

    PhD, MD Bartłomiej Baumert

  22. microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma

    Article • Leukemia & Lymphoma, June 2021, Taylor & Francis

    PhD, MD Bartłomiej Baumert

  23. Long-Term Effects of Adjuvant Intravitreal Treatment with Autologous Bone Marrow-Derived Lineage-Negative Cells in Retinitis Pigmentosa

    Article • Stem Cells International, June 2021, Wiley

    PhD, MD Bartłomiej Baumert

  24. Protective environment in hematopoietic cell transplantation centers: results of a survey of the Polish Federation of Bone Marrow Transplant Centers

    Article • Acta Haematologica Polonica, April 2021, VM Media SP. zo.o VM Group SK

    PhD, MD Bartłomiej Baumert

  25. Humoral Influence of Repeated Lineage-Negative Stem/Progenitor Cell Administration on Articulatory Functions in ALS Patients

    Article • Stem Cells International, December 2020, Wiley

    PhD, MD Bartłomiej Baumert

  26. Antimicrobial prophylaxis in patients after hematopoietic cell transplantation: results of a survey of the Polish Federation of Bone Marrow Transplant Centers

    Article • Acta Haematologica Polonica, September 2020, VM Media SP. zo.o VM Group SK

    PhD, MD Bartłomiej Baumert

  27. The Relationship between Selected Demographic Factors and Speech Organ Dysfunction in Sporadic ALS Patients

    Article • Medicina, August 2020, MDPI AG

    PhD, MD Bartłomiej Baumert

  28. Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS

    Article • Cells, August 2020, MDPI AG

    PhD, MD Bartłomiej Baumert

  29. Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients

    Article • International Journal of Molecular Sciences, February 2020, MDPI AG

    PhD, MD Bartłomiej Baumert

  30. The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction

    Article • International Journal of Medical Sciences, January 2020, Ivyspring International Publisher

    PhD, MD Bartłomiej Baumert

  31. Articulation recovery in ALS patients after lineage-negative adjuvant cell therapy - preliminary report

    Article • International Journal of Medical Sciences, January 2020, Ivyspring International Publisher

    PhD, MD Bartłomiej Baumert

  32. Comparative assessment and monitoring of deterioration of articulatory organs using subjective and objective tools among patients with amyotrophic lateral sclerosis

    Article • BMC Neurology, October 2019, Springer Science + Business Media

    PhD, MD Bartłomiej Baumert

  33. Novel Evidence of the Increase in Angiogenic Factor Plasma Levels after Lineage-Negative Stem/Progenitor Cell Intracoronary Infusion in Patients with Acute Myocardial Infarction

    Article • International Journal of Molecular Sciences, July 2019, MDPI AG

    PhD, MD Bartłomiej Baumert

  34. Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients

    Article • Stem Cells International, June 2019, Hindawi Publishing Corporation

    Dr Iwona E Rotter, PhD, MD Bartłomiej Baumert

  35. Potential Leukemic Cells Engraftment After Hematopoietic Stem Cell Transplantation From Unrelated Donors With Undiagnosed Chronic Leukemia

    Article • Transplantation Proceedings, December 2018, Elsevier

    PhD, MD Bartłomiej Baumert

  36. Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles

    Article • International Journal of Molecular Sciences, April 2018, MDPI AG

    PhD, MD Bartłomiej Baumert

  37. Neuroprotective and Antiapoptotic Activity of Lineage-Negative Bone Marrow Cells after Intravitreal Injection in a Mouse Model of Acute Retinal Injury

    Article • Stem Cells International, January 2015, Hindawi Publishing Corporation

    PhD, MD Bartłomiej Baumert

  38. Long-Term Neuroprotective Effects of NT-4–Engineered Mesenchymal Stem Cells Injected Intravitreally in a Mouse Model of Acute Retinal Injury

    Article • Investigative Ophthalmology & Visual Science, December 2013, Association for Research in Vision and Ophthalmology (ARVO)

    PhD, MD Bartłomiej Baumert

  39. Endogenous regeneration of damaged retinal pigment epithelium following low dose sodium iodate administration: An insight into the role of glial cells in retinal repair

    Article • Experimental Eye Research, July 2013, Elsevier

    PhD, MD Bartłomiej Baumert

  40. Bone Marrow of Multiorgan Donors Underutilized

    Article • Transplantation, January 2012, Wolters Kluwer Health

    PhD, MD Bartłomiej Baumert

  41. Stem Cells are Mobilized from the Bone Marrow into the Peripheral Circulation in Response to Retinal Pigment Epithelium Damage—A Pathophysiological Attempt to Induce Endogenous Regeneration

    Article • Current Eye Research, June 2011, Taylor & Francis

    PhD, MD Bartłomiej Baumert

  42. Sodium Iodate Selectively Injuries the Posterior Pole of the Retina in a Dose-Dependent Manner: Morphological and Electrophysiological Study

    Article • Neurochemical Research, August 2010, Springer Science + Business Media

    PhD, MD Bartłomiej Baumert

  43. Potential Application of Adult Stem Cells in Retinal Repair—Challenge for Regenerative Medicine

    Article • Current Eye Research, January 2009, Taylor & Francis

    PhD, MD Bartłomiej Baumert

  44. An optimization of hematopoietic stem and progenitor cell isolation for scientific and clinical purposes by the application of a new parameter determining the hematopoietic graft efficacy.

    Article • Folia Histochemica et Cytobiologica, December 2008, VM Media SP. zo.o VM Group SK

    PhD, MD Bartłomiej Baumert

  45. The influence of 3,3',5-triiodo-l-thyronine on human haematopoiesis

    Article • Cell Proliferation, June 2007, Wiley

    PhD, MD Bartłomiej Baumert